<SEC-DOCUMENT>0001140361-25-035339.txt : 20250918
<SEC-HEADER>0001140361-25-035339.hdr.sgml : 20250918
<ACCEPTANCE-DATETIME>20250918085052
ACCESSION NUMBER:		0001140361-25-035339
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20250918
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250918
DATE AS OF CHANGE:		20250918

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PDS Biotechnology Corp
		CENTRAL INDEX KEY:			0001472091
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				264231384
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37568
		FILM NUMBER:		251321847

	BUSINESS ADDRESS:	
		STREET 1:		303A COLLEGE ROAD EAST
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540
		BUSINESS PHONE:		800-208-3343

	MAIL ADDRESS:	
		STREET 1:		303A COLLEGE ROAD EAST
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Edge Therapeutics, Inc.
		DATE OF NAME CHANGE:	20090911
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20055698_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:cef="http://xbrl.sec.gov/cef/2025" xmlns:cyd="http://xbrl.sec.gov/cyd/2025" xmlns:pdsb="http://pdsbiotech.com/20250918" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_b894b3a0529d440db037ebf3b5141836" contextRef="c20250918to20250918" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_72b95a79dcbd45e79667daecf28f42b5" contextRef="c20250918to20250918">0001472091</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_2792a50484234d849d7a1cfd6c745eef" contextRef="c20250918to20250918">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="pdsb-20250918.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20250918to20250918"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001472091</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-09-18</xbrli:startDate><xbrli:endDate>2025-09-18</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-size: 10pt;"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">WASHINGTON, DC 20549</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <div>
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_b9fbc03d8dfd4c38831bbec08e92d1c1" contextRef="c20250918to20250918">8-K</ix:nonNumeric></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: center; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Securities Exchange Act of 1934</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_bcf2bfe266a14c8b836f2cd46292526e" contextRef="c20250918to20250918" format="ixt:date-monthname-day-year-en">September 18, 2025</ix:nonNumeric></div>

      <div><br/></div>

      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/>
      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_af425c2e22ad4beb91e275e6d4891a15" contextRef="c20250918to20250918">PDS BIOTECHNOLOGY CORPORATION</ix:nonNumeric><br/>
      </div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Exact Name of Registrant as Specified in Charter)</div>

      <div><br/></div>

      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/>
      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="text-decoration: underline;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_5dac21d1381c4411b8825e7badaf203e" contextRef="c20250918to20250918" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
                </span></div>
            </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="text-decoration: underline;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_d33a1fb5632f47d084d03a72e69ac9da" contextRef="c20250918to20250918">001-37568</ix:nonNumeric><br/>
                </span></div>
            </td>

    <td style="width: 32.96%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="text-decoration: underline;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_a396c30542084584bcffec811d6203f2" contextRef="c20250918to20250918">26-4231384</ix:nonNumeric><br/>
                </span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>

    <td style="width: 32.96%; vertical-align: top; font-size: 10pt;" rowspan="1">&#160;</td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(State or Other Jurisdiction of Incorporation)</div>
            </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(Commission File Number)</div>
            </td>

    <td style="width: 32.96%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">(I.R.S. Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;"> <br/>
        </span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_447a95e479cf422390eb37f7b4c2959a" contextRef="c20250918to20250918">303A College Road East</ix:nonNumeric>,
          <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_ce8bb625b81a4508a42e39549496afb2" contextRef="c20250918to20250918">Princeton</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_86821b755bc14bf9854b1722f58c7cca" contextRef="c20250918to20250918">NJ</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_7ef35d3975dd40829dcb78c5b57b9164" contextRef="c20250918to20250918">08540</ix:nonNumeric></span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Address of Principal Executive Offices, and Zip Code)</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="text-decoration: underline;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_9cf92ff37d674b7a9432945d4da4ef88" contextRef="c20250918to20250918">800</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_d30dd23bd7e342a89c49df6cf539c418" contextRef="c20250918to20250918">208-3343</ix:nonNumeric></span></div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Registrant&#8217;s Telephone Number, Including Area Code</div>

      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
      </div>

      <hr style="background-color: #000000; border-bottom: medium none; border-left: medium none; border-right: medium none; border-top: medium none; margin: 0px auto; height: 2px; width: 15%; color: #000000; text-align: center; margin-left: auto; margin-right: auto;"/>
      <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(Former Name or Former Address, if Changed Since Last Report)</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
        following provisions (<span style="font-family: 'Times New Roman'; font-style: italic;">see</span> General Instruction A.2. below):</div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 17.6pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_ffb105eecdc4482a809809a281a6a2e7" contextRef="c20250918to20250918" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
              <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-spacing: 0;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: left; vertical-align: top; width: 17.6pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_0283225b171c42c9b9491073d601cb1d" contextRef="c20250918to20250918" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; text-indent: 0.4pt;"><span style="font-size: 10pt;"><span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></span></div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-spacing: 0;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: left; vertical-align: top; width: 17.6pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_6fbaec670ca44c7399a81657a25b4f59" contextRef="c20250918to20250918" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; text-indent: 0.3pt;"><span style="font-size: 10pt;"><span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
                      240.14d-2(b))</span></span></div>
              </td>

  </tr>


</table>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-spacing: 0;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: left; vertical-align: top; width: 17.6pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_2b5f03a1d0f64c95806f52733ee5a5b6" contextRef="c20250918to20250918" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left; text-indent: 0.3pt;"><span style="font-size: 10pt;"><span style="font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
                      240.13e-4(c))</span></span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 46.33%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Title of each class</div>
            </td>

    <td style="width: 20%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Trading Symbol(s)</div>
            </td>

    <td style="width: 34.28%; vertical-align: top; border-width: 2px; border-style: solid; border-color: rgb(0, 0, 0);">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Name of each exchange on which</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 46.33%; vertical-align: middle; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_8c1cc4078f094d198e0a020275f67370" contextRef="c20250918to20250918">Common Stock, par value $0.00033 per share</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 20%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt; text-align: center;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_82d8456b80164da3bc9973d4c48bd8cd" contextRef="c20250918to20250918">PDSB</ix:nonNumeric><br/>
            </td>

    <td style="width: 34.28%; vertical-align: top; border-left: 2px solid rgb(0, 0, 0); border-right: 2px solid rgb(0, 0, 0); border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="-sec-ix-hidden:Fact_2792a50484234d849d7a1cfd6c745eef">The Nasdaq Capital Market</span><br/>
              </div>
            </td>

  </tr>


</table>
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405 of this
        chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2 of this chapter).</div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_8913ae0cfa8e40fe9f589d350030fca0" contextRef="c20250918to20250918" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

      <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new
        or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes &#9744; No &#9744;</div>

      <div style="font-size: 10pt;">
<div><br/></div>

        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-spacing: 0;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 63pt;">
                <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">Item 8.01</span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><span style="font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Other Events.</span></span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; text-indent: 30pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">On September 18, 2025, PDS Biotechnology Corporation issued a press
          release announcing details of a sub-analysis of the cohort of patients with low PD-L1 expression (CPS 1-19) from the final data for its recently completed </span><span style="text-decoration: underline;"><span style="font-size: 10pt; font-family: 'Times New Roman';">VERSATILE-002</span></span><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> Phase 2 clinical trial.</span></div>

      <div style="text-align: left; text-indent: 30pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;"> </span><span style="font-size: 10pt;"><br/>
        </span></div>

      <div style="text-align: justify; text-indent: 30pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">A copy of the press release is filed herewith as Exhibit 99.1 and incorporated by reference herein.</div>

      <div style="font-size: 10pt;"><br/>
      </div>

      <div>
        <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-spacing: 0;" class="DSPFListTable">


  <tr style="vertical-align: top;">

    <td style="text-align: right; vertical-align: top; width: 63pt;">
                <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; color: #000000;">Item 9.01</span></div>
              </td>

    <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: left;"><span style="font-size: 10pt;"><span style="font-family: 'Times New Roman'; font-weight: bold; color: rgb(0, 0, 0);">Financial Statements and Exhibits.</span></span></div>
              </td>

  </tr>


</table>
      </div>

      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(d) Exhibits.</div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000; border-spacing: 0;">


  <tr>

    <td style="width: 9.84%; vertical-align: top; border-bottom: #000000 2px solid;">
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit</div>
              <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div>
            </td>

    <td style="width: 0.09%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 90.07%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 9.84%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 0.09%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 90.07%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9.84%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-family: 'Times New Roman';"><a href="ef20055698_ex99-1.htm">99.1</a></div>
            </td>

    <td style="width: 0.09%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 90.07%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Press Release Dated September 18, 2025.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 9.84%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 0.09%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 90.07%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 9.84%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">104</div>
            </td>

    <td style="width: 0.09%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 90.07%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Cover Page Interactive Data File (embedded within the Inline XBRL Document).</div>
            </td>

  </tr>


</table>
      <div> <br/>
      </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

      </div>

      <div style="text-align: left;">
        <div style="text-align: center;"> <span style="font-weight: bold;">Signature</span></div>

        <div> <br/>
        </div>

        <div style="text-indent: 36pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
          undersigned hereunto duly authorized.</div>

        <div style="font-size: 10pt;"><br/>
        </div>

        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; color: rgb(0, 0, 0); border-spacing: 0;">


  <tr>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="vertical-align: top; font-size: 10pt;" colspan="2">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">PDS BIOTECHNOLOGY CORPORATION</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="vertical-align: top; font-size: 10pt;" colspan="2">&#160;</td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; text-align: left;">Date:&#160; September 18, 2025</div>
              </td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">By:</div>
              </td>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="text-decoration: underline;">/s/ Frank Bedu-Addo, Ph.D.</span></div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="vertical-align: top; font-size: 10pt;" colspan="2">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Name: Frank Bedu-Addo, Ph.D.</div>
              </td>

  </tr>

  <tr>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;" colspan="1">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="vertical-align: top; font-size: 10pt;" colspan="2">
                <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Title: President and Chief Executive Officer</div>
              </td>

  </tr>


</table>
        <div><br/>
        </div>

        <div><br/></div>

        <div style="font-size: 10pt;">
          <hr style="height: 2px; color: rgb(0, 0, 0); background-color: rgb(0, 0, 0); margin-left: auto; margin-right: auto; border: medium none;"/></div>

      </div>

    </div>

  </div>

  <div><span style="font-size: 10pt;"> </span></div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ef20055698_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 25.9.1.5330
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <font style="font-size: 10pt;">
  </font>
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right; font-weight: bold;"> <font style="font-size: 10pt;">Exhibit 99.1<br>
      </font></div>
    <div><br>
      <img src="image00001.jpg">
      <div style="font-size: 10pt;">
        <div style="text-align: left;"><br>
        </div>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">PDS Biotech Sets Significant Benchmark in Head and Neck Cancer by Achieving Extended Survival in Low PD-L1 Expression (CPS 1&#8211;19) Cohort in
        VERSATILE-002 Trial, Potentially Eliminating Need for Chemotherapy in the Population</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">First combination therapy to report 29.5 months of Median Overall Survival
          (mOS); Standard of care Keytruda</font><font style="font-size: 10pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-family: 'Times New Roman'; font-style: italic;"> (pembrolizumab) alone (10.8 months) and Keytruda</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-family: 'Times New Roman'; font-style: italic;"> + chemotherapy (12.3 months) in patients with CPS 1-19*</font></font></div>
      <div style="font-size: 10pt;">&#160;</div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Encouraging efficacy signal observed in difficult to treat category of advanced head and neck cancer patients</div>
      <div style="font-size: 10pt;"><br>
      </div>
      <div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">PRINCETON, N.J., September 18, 2025 -- PDS Biotechnology Corporation (Nasdaq: PDSB) (&#8220;PDS Biotech&#8221; or the &#8220;Company&#8221;), a late-stage immunotherapy company
          focused on transforming how the immune system targets and kills cancers, today announced details of a sub-analysis of the cohort of patients with low PD-L1 expression (CPS 1-19) from the final data for its recently completed <u><font style="font-family: 'Times New Roman';">VERSATILE-002</font></u> Phase 2 clinical trial. The VERSATILE-002 trial evaluated PDS0101 (Versamune<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> HPV) + Keytruda<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> in patients with HPV16-positive first-line
          recurrent and/or metastatic head and neck squamous cell cancer (&#8220;1L R/M HNSCC&#8221;).</div>
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;This is great news for these patients who may now have the possibility of a well-tolerated treatment without chemotherapy&#8221; stated Prof. Kevin Harrington,
          M.D., Head of the Division of Radiotherapy, The Institute of Cancer Research, London.</div>
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;Patients with low levels of PD-L1 expression have typically shown poor response to immune checkpoint inhibitor therapy, leaving HNSCC patients in this
          sub-type with few viable treatment options and a poor prognosis,&#8221; said Kirk Shepard, M.D., Chief Medical Officer of PDS Biotech.&#160; &#8220;This sub-analysis of survival data from the CPS 1-19 patient cohort appears to show that the multifunctional T cell
          immune response of PDS0101 treatment may overcome the documented limitations of immune checkpoint inhibitor therapy and significantly improve survival in one of the most difficult-to-treat patient populations. This is a very encouraging finding,
          pointing to the potential of PDS0101 to improve treatment outcomes in a patient group that has historically derived limited benefit from current standards of care.&#8221;</div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Approximately 60% of the patients enrolled (n=53) in the VERSATILE-002 trial had low PD-L1 expression, a difficult to treat subset of the overall HNSCC
          patient population. The sub-analysis of this patient cohort shows:</div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" id="z61ff118292024454b2a1660ea8e5023d" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
                <div style="font-family: 'Times New Roman';">Median overall survival (mOS) for patients within the CPS 1-19 cohort (n=32) was 29.5 months.</div>
              </td>
            </tr>

        </table>
        <table cellspacing="0" cellpadding="0" id="zb17eae9eebbb46559e4e9f372a903e70" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 18pt;">&#160;</td>
              <td style="width: 27pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>
              <td style="width: auto; vertical-align: top; text-align: justify; font-size: 10pt;">
                <div style="font-family: 'Times New Roman';">Published mOS in this CPS cohort was 10.8 months with Keytruda<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> monotherapy and 12.3 months with Keytruda<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> plus chemotherapy*</div>
              </td>
            </tr>

        </table>
      </div>
      <div>
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">The Company announced mOS results for the full study population of 39.3 months from the VERSATILE-002 trial on August 25, 2025, and the full data set for
          the trial is expected to be published later this year.</div>
      </div>
      <div style="font-size: 10pt;">
        <div><br>
        </div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">*No head-to-head studies have been performed comparing Keytruda</font><font style="font-size: 10pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-family: 'Times New Roman'; font-style: italic;"> (pembrolizumab) monotherapy and Keytruda</font><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup><font style="font-family: 'Times New Roman'; font-style: italic;"> plus chemotherapy with PDS0101 *</font></font></div>
      <div>
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About the VERSATILE-002 Trial</div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">VERSATILE-002 (<u><font style="font-family: 'Times New Roman';">NCT04260126</font></u>) is an open-label, multi-center Phase 2 clinical trial
          evaluating the safety and efficacy of PDS0101, an HPV16-targeted immunotherapy, in combination with pembrolizumab for <font style="font-family: 'Times New Roman'; color: rgb(58, 58, 58);">unresectable, </font>recurrent or metastatic
          HPV16-positive HNSCC. The trial is designed to assess the combination therapy's impact on patients who are either naive to or refractory to immune checkpoint inhibitors.</div>
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About PDS Biotechnology</div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">PDS Biotechnology is a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers. The
          Company has initiated a pivotal clinical trial to advance its lead program in advanced HPV16-positive head and neck squamous cell cancers. PDS Biotech&#8217;s lead investigational targeted immunotherapy PDS0101 (Versamune&#174; HPV) is being developed in
          combination with a standard-of-care immune checkpoint inhibitor, and also in a triple combination including PDS01ADC, an IL-12 fused antibody drug conjugate (ADC), and a standard-of-care immune checkpoint inhibitor. PDS01ADC is being evaluated in
          multiple phase 2 trials in various cancer indications in combination with standard of care.</div>
        <div style="font-size: 10pt;"><br>
        </div>
      </div>
      <div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">For more information, please visit </font><u><font style="font-size: 10pt; font-family: 'Times New Roman';">www.pdsbiotech.com</font></u></div>
        <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
          </font></div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="font-size: 10pt;">
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Forward Looking Statements</div>
      </div>
      <div style="font-size: 10pt;">
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman';">This communication contains forward-looking statements (including within the meaning of Section 21E of the United States Securities Exchange Act of
          1934, as amended, and Section 27A of the United States Securities Act of 1933, as amended) concerning PDS Biotechnology Corporation (the &#8220;Company&#8221;) and other matters. These statements may discuss goals, intentions and expectations as to future
          plans, trends, events, results of operations or financial condition, or otherwise, based on current beliefs of the Company&#8217;s management, as well as assumptions made by, and information currently available to, management. Forward-looking
          statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;plan,&#8221; &#8220;likely,&#8221; &#8220;believe,&#8221;
          &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intend,&#8221; &#8220;forecast,&#8221; &#8220;guidance&#8221;, &#8220;outlook&#8221; and other similar expressions among others. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not
          guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors, including, without limitation: the Company&#8217;s ability to protect its intellectual
          property rights; the Company&#8217;s anticipated capital requirements, including the Company&#8217;s anticipated cash runway and the Company&#8217;s current expectations regarding its plans for future equity financings; the Company&#8217;s dependence on additional
          financing to fund its operations and complete the development and commercialization of its product candidates, and the risks that raising such additional capital may restrict the Company&#8217;s operations or require the Company to relinquish rights to
          the Company&#8217;s technologies or product candidates; the Company&#8217;s limited operating history in the Company&#8217;s current line of business, which makes it difficult to evaluate the Company&#8217;s prospects, the Company&#8217;s business plan or the likelihood of
          the Company&#8217;s successful implementation of such business plan; the timing for the Company or its partners to conduct clinical trials for PDS0101 (Versamune<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> HPV), PDS01ADC, PDS0103 (Versamune<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MUC1) and other Versamune&#174;
          based product candidates; the future success of such trials; the successful implementation of the Company&#8217;s research and development programs and collaborations, including any collaboration studies concerning PDS0101 (Versamune<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> HPV),
          PDS01ADC, PDS0103 (Versamune<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> MUC1) and other Versamune<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> based product candidates and the Company&#8217;s interpretation of the results and findings of such programs and collaborations and whether such results are sufficient to
          support the future success of the Company&#8217;s product candidates; the success, timing and cost of the Company&#8217;s or its partners&#8217; ongoing clinical trials and anticipated clinical trials for the Company&#8217;s current product candidates, including
          statements regarding response rates, the timing of initiation, pace of enrollment and completion of the trials (including the Company&#8217;s ability to fully fund its disclosed clinical trials, which assumes no material changes to the Company&#8217;s
          currently projected expenses), futility analyses, presentations at conferences and data reported in an abstract, and receipt of interim or preliminary results (including, without limitation, any preclinical results or data), which are not
          necessarily indicative of the final results of the Company&#8217;s ongoing clinical trials; any Company statements about its understanding of product candidates mechanisms of action and interpretation of preclinical and early clinical results from its
          clinical development programs and any collaboration studies; the Company&#8217;s ability to continue as a going concern; and other factors, including legislative, regulatory, political and economic developments not within the Company&#8217;s control. The
          foregoing review of important factors that could cause actual events to differ from expectations should not be construed as exhaustive and should be read in conjunction with statements that are included herein and elsewhere, including the other
          risks, uncertainties, and other factors described under &#8220;Risk Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and elsewhere in the documents we file with the U.S. Securities and Exchange
          Commission. The forward-looking statements are made only as of the date of this press release and, except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other
          forward-looking statements, whether as a result of new information, future events or otherwise.&#8239;</div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman';"> <br>
        </div>
      </div>
      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Versamune&#174; is a registered trademark of PDS Biotechnology Corporation.</div>
        <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Keytruda&#174; is a registered trademark of Merck Sharp &amp; Dohme Corp., a subsidiary of Merck &amp; Co., Inc.</div>
      </div>
      <div>
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Investor Contact:</div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Mike Moyer</div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">LifeSci Advisors</div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Phone +1 (617) 308-4306</div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Email: </font><u><font style="font-size: 10pt; font-family: 'Times New Roman';">mmoyer@lifesciadvisors.com</font></u></div>
        <div style="font-size: 10pt;"><br>
        </div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Media Contact:</div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">David Schull</div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Russo Partners</div>
        <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Phone +1 (858) 717-2310</div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">Email: </font><u><font style="font-size: 10pt; font-family: 'Times New Roman';">david.schull@russopartnersllc.com</font></u></div>
        <div style="text-align: left; font-family: 'Times New Roman'; font-size: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
          </font></div>
      </div>
      <font style="font-size: 10pt;"><br>
      </font>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
  <font style="font-size: 10pt;">
  </font>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>pdsb-20250918.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.9.1.5330 Broadridge-->
<xs:schema targetNamespace="http://pdsbiotech.com/20250918" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:pdsb="http://pdsbiotech.com/20250918" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:srt-types="http://fasb.org/srt-types/2025">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="pdsb-20250918_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="pdsb-20250918_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://pdsbiotech.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2025" schemaLocation="https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>pdsb-20250918_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.9.1.5330 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>pdsb-20250918_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 25.9.1.5330 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://pdsbiotech.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="pdsb-20250918.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://pdsbiotech.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image00001.jpg
<TEXT>
begin 644 image00001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1"  M /@# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZHS3/-7.
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MH)KI>;YF7 :/@9R?7U%>?6?@+Q O[/?B*WFL)(]4U*\_M%+!5.]$W+\H7LV
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;;EAC&6SP./U-=[BEQZT (% Z<#I12T4 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Sep. 18, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep. 18,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">PDS BIOTECHNOLOGY CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001472091<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">26-4231384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">303A College Road East<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Princeton<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">08540<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">208-3343<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.00033 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PDSB<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20055698_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pdsbiotech.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20055698_8k.htm">ef20055698_8k.htm</File>
    <File>pdsb-20250918.xsd</File>
    <File>pdsb-20250918_lab.xml</File>
    <File>pdsb-20250918_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20055698_8k.htm": {
   "nsprefix": "pdsb",
   "nsuri": "http://pdsbiotech.com/20250918",
   "dts": {
    "inline": {
     "local": [
      "ef20055698_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "pdsb-20250918.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-roles-2025.xsd",
      "https://xbrl.fasb.org/us-gaap/2025/elts/us-types-2025.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "pdsb-20250918_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pdsb-20250918_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2025": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2025": 22
   },
   "report": {
    "R1": {
     "role": "http://pdsbiotech.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20250918to20250918",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20055698_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20250918to20250918",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20055698_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CityAreaCode",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "Security12bTitle",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "TradingSymbol",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://pdsbiotech.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001140361-25-035339-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-035339-xbrl.zip
M4$L#!!0    ( %E&,EO*S H-&1,  "9V   1    968R,# U-38Y.%\X:RYH
M=&WM/6MSXCBVW^=7Z#)WMY.J&/S$-IW.5IHD/>RDDVS(WIV]7[9D20;=-C9C
MFR3<7[]'LDT,&# AK\DFU55M6Z^C<W3>DCC\R_TH0+<L3G@4?OFD-=5/B(4D
MHCP<?/ETW._V>I_^<O33X3"%:E U3#KW7ASP+XUAFHX[K=;=W5U3?&E&\:"E
MJZK1XF&2XI"P1EX_X.&/-=5%L8>36?7[I?IWAJRMN:[;DJ6SJ@FOJ@C=:JW?
MOI_WR9"-L+((CQB>/C0L0]-N985%59Y$IJ[9ZR:;U2@:)'$ZJ^SCQ),5X2-4
MUJU9K_>K.M0$]F"&[+>OU^</U=/J^@]56VF,P\2/XA%.@8YB-%51=4732YTH
M"2-S'<%[<Q#=KNU'LQ3540RMZ&>2* .,Q\N3S OF)DK9 IJ+$:%@KB*))F$:
M3ZLKYX7S#29Q#,MT58N\=!Z8-%;2Z9@EU<B$XI8H%FU,1=7*<T[CE2O ;4%I
M43'$G"35(,FB.7@23JJK0L%\Q70<KZ@))7-5V3T95E<5)?,89/X*Y#%_ON*4
MKJ@XI7,5QS3Q9C7%"X]21H9-$HUD/=75G+SN:O86<J9Q]!-"AT.&J7B QY2G
M 3LZ;&7_9]_^2U'0.2<L3!A%:=1!7^,(TYC3 9,5Y-])1"8C%J:(Q RG4'&2
M@%PK5457UY<^#QC2K:;;U)J68:@/S;O1>!KSP3!% )R%%"2F46ZM*#DT(Y9B
M).:DL-\G_/9+HQN%*0RLW,"2:B"2O7UII.P^;<DYMD"HMK(Y_G3H172*DG0:
ML"\-'^HJ/A[Q8-I!GV[XB"7H@MVAZVB$PT^?D2Q/^/^S#M+4<?H9B3X5'/!!
MV$$!\^$+B8(H[J"?5?GW&7F8_!C$P$94*8I\^?<94'U(^2WB0..3_M49%U+@
M%TXI"QL%0)0GXP #,&$4,FAQR.\[ G 69X^RMGR$"A> [Y@3%.*1:,IXYQ@(
M0 41S@(\:,B1SC!)_^4YKND96+5TEYJF2CW5L)GG&YZEF9ICM'.LW:?78J62
M8@6ET<-:R@35EP8(MX[/[QD%O 6@28[D?X>M.9!60W@:PL*:=@'$& >]D++[
M7]FT!*FM>ZZ%;9<2CYH6L]UVVZ:8$5]W?%/WK,V0'@$9--/6X:4V5'T&8@S@
M.@7.Q>& 74!)"2C==G5LJ:9CZH9)'=.E-M:(3]O$!AB97P.HB^/^R?'?E@!J
MS1,U9CX3TI0E1X="^782J5:A6R25<6<8BQ$$PRM%W\W[A#;R8B%4OS02/AH'
M#%:][+[<IWQ-HDDLWZ1QT<E!E[.M!#VOQR3EBC=.Q;O/68PDC*Q2VW5[O\[3
M8['Q4?%IOO<Q8">BQ1N8%'%Z C+E2 "EJ*ZB.46[A[(9F'1%U:*D>"\&:<WA
MH4#:#$NM$@NV@']S+LX95FAS9<B$X.H@'O*4X^!S)E1%W<-DC,,Y:5.2)HTC
M=-@2%8J.BU:9G!O&14,OBF'X7"B@[$WQHC2-1M#5^!XE4< I\@*0/;/R-!IW
MD+E86( * -P_"*]<0JT17G.2#S1!RN+/:(3C 0\5(0@["$_2:/8ISD:1WX3X
ME1.:32U[+F97U7,^>CSP]M0#)/[MY]*XIK0VA;26'^[R&7M10 'E?[_HW9R>
MH/[-\<UI_P'OKPM4_[3[]^O>3>^TCXXO3M#I;]U?CB^^G:+NY??OO7Z_=WGQ
MPI#JJR#]QW'_E][%MYO+BP-TT@4E;9GN"\.FKH(-'7IQ:[;"EH ZFAD;)=8J
M^$$OL\,:75X45<ULGDUK,\<+H\]9A;ZSR^OO:*6*+,R[S,AZL"Q<WR.J01WJ
M4Y,8CF-HGL>(ZC!7IQK1:JA&1_EU62^^C17U+E9,U<1 W%R?7MR@Z].KR^N;
M1Z%[-K$GP?35)$XF&+R'-$)@C0F/&&D&BF*D67MT'T4^2H?L#0":FXH<VA;6
M(CHFJ0!0<PWS#4 HC!P!SC4;1W&*]HIWAL',84F*V*UPTV)9S.A^9S/37TE3
MZ30SH,K<#W:YYS.]W<::21P/7 E?)]1LZZYNZ6VVI5]!H7=E!"V& @2%XJDR
M!:@5<)  [^.4C3RP-S7G0#J'FX7&D50("]_?%"?76R>-]79DO64SMTH6IULR
M1==;K&45BY;-UY<0U_I*,VJ#UWG-!CP14;=TP;_#X%I:1&>ZCJGI,<_5F&Y;
MK$U-Q]6P5L?IO#KIHZ^]RYO3[B\7E^>7W_X)MMLUR-;C&VF\+:S4M7;*BPN,
MO=-[P (22,GD1H$FA!/4'S,B7#4*W@WJ#L';8O'^'YG54NP%##H+ EB[1(3>
M&VI#OH\QI<5[-HA\?&RLZ([3="A>U#_-G#*87X#'"=0IGFK%E++&.;P=I)9-
MDX<0FG@\3..CTI>\^#"EQ31RJ P#@+IE<<H)#HK1P65<GD=COK_GX>\%"2>[
MI8Q$L8R-=Q"L#18+7WLSE_=":#;.6_934"G=+*C=C6B9Z2V*B:Y1S7 T8IJ:
MYCF.;C';PQ3[NFILJ;M$P%\$(U(VCJ-; 9-06B<LP'<X7@Z/S4G1:FDZ7Y+2
M>F0UWRM9SWC H P,@!(-J6%@S?>LMJ'[IDU5QZ2J@6V=M5U,7(IK10LUQ;"M
MMO-R--*;;ON]DND&W_?RZ!Z1K9=HA@VW30S5,G4@E^688$/ZC#B:1MO =KY>
M@V9Z6S%U SC7?&JB_20_Q8N?GEZHHCBZ$T!]:6B-HS__K+75S\_!Y#L-L]4Z
MK3'2BR'W)7BFVI*2^D9XK9?@K<;HK^ J)I1G[BR85G.Z:?\="?IJ;'2CT8@G
M8K<#$N(;9;)@MWF_.>%9/?5>\[K9;Z+3T3B(IK 2YH4BNHB:=="PQ#'YPT_P
M59BQ6X;3G]9MJ*\ST--YC:\UA0UJ[YC2F"5)_M\YM-%**L\T;>Q:S+1= IZF
M;K@J\PS;MSV3Z*[EUC%3#-4X1EWP&=B P1PQ1:<X21?5WT%I[=2#N N/E_%-
M=!>6X"7,\;RV;GF.ADU+=;"I,\.U3-=TV]CWZJCHJYB'A*51N 1B3<"D)+V,
MK\":YG)#T0PZI^WHFF=;ED<TT_-=QS(]S=9UWW*(34@=;%[\=1&LFE!=16#C
M!__+QPO.A,U\PZ*&:UN4FJJCB_RU[1#+LVS/U=IF'4,4YJ$NQ[3>"JOLY1@0
M:DP2EX]Q@$[O&9FD_):A2Q^$&TL.$ XI @0A@:&*0,%S KX-0^^M)+A@B>.8
MX042 ^^ZNN\;-FW;I@<,;1JZ:UK4I-ADON/4R72H2P3>7[WPSB/0;U?#**SR
M>U1*=<.C-C-,'3LN,5WJMXEO&?"HU8%%%UO-#--XNRON(0[UYY^!X^W/";IA
M 1L+C.2FQ(&PJ(*)B-H@03*YZ-X Z.LRD:6T_NJXUT*.?\0HGXSF\_]9Q*NJ
M) ]\517)30%S!5FPK(/4\7T>/IN+U15!+.M/RZC:?4O :\FRLRB&U9Y'/&.4
MO^82[@!Q7T0ZPP&CJ"^4#SH'79OG4VJ*M.I WO8"K3MDY(=(?2$\'L?1..;"
MP?"B>^2Q(+H3H(I",0/D*+\BGP>"&7B"N-@&1^6&/93PT21(<<BB21),40+R
M,/&GLF7>(/( ;ESX*:(@?@@#2[D)@GV:E\VL#!\,DNA.M!=1+RXL_03M+:<0
M-DY9U.T@#KJ5$YAUPE@NA] W%K(8-$TO!& FF2=UW-2;V?SW.PODJ!?=)0%.
MDFP7WCE,\D8T>J) [ZM$<S6[V1:05'I%3Y(>7V,!_R/F*2PUX>Q-PMS!24K*
MRO<]3;48(Y28I@/:2G7A'];!N&QCG=F/"+1Z411X&-9>"IP@P@VN;9J?EU59
M3:<RDU.5R%LFYU9.YN.B<3E& 2\EE*)Q*45^/8%5;NI6SIJ"7TN):9&/WM-L
MU#V[1KJA-J'B4WN;)6^N'LL]91:ES#K5O+PPK46F*J"I(OD2/1<7S?*2J%PY
M\ZRYAG_Z$0@](%PX^ ZR'01\4&(>57<,'3PQS=:(J1/7 Q],4VV#ME6->!I]
M0>;9%1.9YJ^(SJY5H?(+#T7X!.C=-)?-_ U>P*855\6BC:,'HH#]DE%EF0$U
M$RN:7N+!N1TA,PXTU696<W]F7*^*1Z^(A%6$35>PYKI=;Q^,NANC7L5,*#FQ
MEUKNA!/F50Q^[YQKUO8]S$C;5@DV36(;KHL=K6W9&)C8]"WW/XUAC1=B6"".
M0DK4V:0\-9,J^IZWOX%[ER:?_64\G?7PP=7OB:M[23)A<35OZY[EJP;6J.JW
M3>):CMKV+=TV#,8L;'E;'J/YX.UGXVV#*>8>V86W\QY>@[>?,YQ0<A(R_Y[%
MC,XA<+;Y5@K'/!8 2'N<H_W>MU&9[>;JO'0^7EY5AM,*$+)XASR94Y[4"E_Q
MY?>#W(C3G]FF83+,9/PN65M=?8\XBK$,//>G(R\*]I(=\_E-W7E&)#T6)SO(
MFF(_J5Q"K)"_(%KNAIP,JT7ILP/U(/6>?3?0*MDPXI0&BW%\?790;WX5SH?T
M-]0JT@6KJKW6YK)-QVXUW9,"IYSD)1HAIFH[ONJ:5',=IF(5S"C;\MNV8:LU
M,ES"JH/5UD\C\N, C7&,;G$P8>B_U28L'L- 8W%X=5AS>^:SBK]77 -569PU
M),N%7B;SRO32J6-:;<]1M;9)L>$1U[4-:A+3\:A#:L2IQ!;ZKYLI\:02]3^
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M-97?X1B'FFDY0G"^E *3DUGQ4"W]AG)K)HA<M>O4XB U_"R-X.-ZJG(XFYW
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M $=XV,_S?(6I,_)&.0P^(&\/?^-86EP$4 S'I:!WU1=$I>GNNC"7&UX=37C
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M7V5X.3DM,2YH=&U02P$"% ,4    " !91C);Q!A!W$0#   _#P  $0
M        @ '6)@  <&1S8BTR,#(U,#DQ."YX<V102P$"% ,4    " !91C);
MKDAA=WH(   P5@  %0              @ %)*@  <&1S8BTR,#(U,#DQ.%]L
M86(N>&UL4$L! A0#%     @ 648R6V5%_$#;!0  ]3X  !4
M ( !]C(  '!D<V(M,C R-3 Y,3A?<')E+GAM;%!+!08     !0 % $<!   $
%.0     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>ef20055698_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="pdsb-20250918.xsd" xlink:type="simple"/>
    <context id="c20250918to20250918">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001472091</identifier>
        </entity>
        <period>
            <startDate>2025-09-18</startDate>
            <endDate>2025-09-18</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20250918to20250918"
      id="Fact_b894b3a0529d440db037ebf3b5141836">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20250918to20250918"
      id="Fact_72b95a79dcbd45e79667daecf28f42b5">0001472091</dei:EntityCentralIndexKey>
    <dei:SecurityExchangeName
      contextRef="c20250918to20250918"
      id="Fact_2792a50484234d849d7a1cfd6c745eef">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20250918to20250918"
      id="Fact_b9fbc03d8dfd4c38831bbec08e92d1c1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20250918to20250918"
      id="Fact_bcf2bfe266a14c8b836f2cd46292526e">2025-09-18</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20250918to20250918"
      id="Fact_af425c2e22ad4beb91e275e6d4891a15">PDS BIOTECHNOLOGY CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20250918to20250918"
      id="Fact_5dac21d1381c4411b8825e7badaf203e">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20250918to20250918"
      id="Fact_d33a1fb5632f47d084d03a72e69ac9da">001-37568</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20250918to20250918"
      id="Fact_a396c30542084584bcffec811d6203f2">26-4231384</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20250918to20250918"
      id="Fact_447a95e479cf422390eb37f7b4c2959a">303A College Road East</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20250918to20250918"
      id="Fact_ce8bb625b81a4508a42e39549496afb2">Princeton</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20250918to20250918"
      id="Fact_86821b755bc14bf9854b1722f58c7cca">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20250918to20250918"
      id="Fact_7ef35d3975dd40829dcb78c5b57b9164">08540</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20250918to20250918"
      id="Fact_9cf92ff37d674b7a9432945d4da4ef88">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20250918to20250918"
      id="Fact_d30dd23bd7e342a89c49df6cf539c418">208-3343</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20250918to20250918"
      id="Fact_ffb105eecdc4482a809809a281a6a2e7">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20250918to20250918"
      id="Fact_0283225b171c42c9b9491073d601cb1d">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20250918to20250918"
      id="Fact_6fbaec670ca44c7399a81657a25b4f59">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20250918to20250918"
      id="Fact_2b5f03a1d0f64c95806f52733ee5a5b6">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20250918to20250918"
      id="Fact_8c1cc4078f094d198e0a020275f67370">Common Stock, par value $0.00033 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20250918to20250918"
      id="Fact_82d8456b80164da3bc9973d4c48bd8cd">PDSB</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20250918to20250918"
      id="Fact_8913ae0cfa8e40fe9f589d350030fca0">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
